Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14075624 | 0.89 | CYP2D6 (0.36) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL12130130 | 0.89 | CYP2D6 (0.36) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL2629586 | 0.89 | CYP2D6 (0.36) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL12781990 | 0.76 | F11 (0.32) | — | |
| SCHEMBL16327915 | 0.73 | F11 (0.36) | CYP2D6THRBHSD17B10CA2 | |
| SCHEMBL9853886 | 0.72 | CYP2D6 (0.61) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL9853884 | 0.72 | CYP2D6 (0.61) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL12136659 | 0.72 | F11 (0.37) | CYP2D6THRBHSD17B10CA2LMNA | |
| SCHEMBL12781989 | 0.72 | — | — | |
| SCHEMBL26442213 | 0.71 | CYP2D6 (0.47) | CYP2D6THRBHSD17B10CA2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8399656-B2 | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides | OTSUKA CHEMICAL CO., LTD. (JP) | 2013-03-19 | — | — | US | disclosed |
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | OTSUKA CHEMICAL CO., LTD. (JP) | 2012-02-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120035345-A1 | PROCESS FOR PREPARING GLYCOPEPTIDES HAVING ASPARAGINE-LINKED OLIGOSACCHARIDES, AND THE GLYCOPEPTIDES | ASNS, BSG, ANPEP | CYP2D6 4698/4885THRB 3563/4885HSD17B10 2573/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.